• Impact of In Utero Epilepsy Med Exposure Studied in Children

    Superior language, motor development for levetiracetam versus sodium valproate exposure
    THURSDAY, Jan. 9, 2014 (HealthDay News) -- Compared to children exposed in utero to sodium valproate, children exposed in utero to levetiracetam for treatment of maternal epilepsy have superior language and motor development at age 36 to 54 months, according to a study published online Jan. 8 in Neurology.
    Rebekah Shallcross, Ph.D., from the University of Liverpool in the United Kingdom, and colleagues assessed the cognitive and language development of children born to women with epilepsy exposed in utero to levetiracetam (53 children) or sodium valproate (44 children). Also included in the study were 131 control children born to women without epilepsy and not taking medication during pregnancy. The Griffiths Mental Development Scales and the Reynell Language Development Scale were used to assess the children at 36 to 54 months of age.
    The researchers found that there was no difference on any scale administered for children exposed to levetiracetam in utero and unexposed control children, after controlling for confounding variables. Compared with children exposed to levetiracetam, on average, children with in utero exposure to sodium valproate scored 15.8 points lower on measures of gross motor skills (P < 0.001), 6.4 points lower on comprehension language abilities (P = 0.005), and 9.5 points lower on expressive language abilities (P < 0.001).
    "This information should be used collaboratively between health care professionals and women with epilepsy when deciding on women's preferred choice of antiepileptic drug," the authors write.
    Several authors disclosed financial ties to pharmaceutical companies, including UCB Pharma, which partially funded the study.
    Abstract (http://www.neurology.org/content/early/2014/01/08/WNL.0000000000000030.abstract )Full Text (subscription or payment may be required) (http://www.neurology.org/content/early/2014/01/08/WNL.0000000000000030.full.pdf+html )Editorial (subscription or payment may be required) (http://www.neurology.org/content/early/2014/01/08/WNL.0000000000000044.short )
  • Join WellZones today.

    Make a Change For LifeLearn more

    Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.

  • HeartSHAPE Spotlight

    At risk for a heart attack? Learn more

    Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.

  • Calories and Energy Needs

    Calorie NeedsLearn more

    How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.

  • Ideal Body Weight

    Ideal Body WeightLearn more

    Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.

  • Body Mass Index

    Body Mass IndexLearn more

    This tool considers your height and weight to assess your weight status.


  • Can we help answer your questions?

    Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.